Table 1.
SPARC IBD Data & Biosamples Collection Summary
Study Enrollment (baseline) | Office Visit | Colonoscopies or sigmoidoscopies (event) | 3 months after event | Quarterly | |
---|---|---|---|---|---|
Data | |||||
Medical record | ╳ | ||||
Ibd smartform | ╳ | ╳ | |||
Colonoscopy and sigmoidoscopy indices | ╳ | ||||
Patient-reported Outcomes | ╳ a | ╳ a | ╳ a | ╳ a | ╳ a |
Biosamples | |||||
Blood | ╳ | ╳ | ╳ | ╳ b | |
Stool | ╳ | ╳ | ╳ | ||
Intestinal Biopsies | ╳ |
aHospitalization is only collected when applicable.
bBlood collected if patient has a change in IBD medications after the colonoscopy/sigmoidoscopy and is scheduled for the clinical visit.